Free Trial
NASDAQ:FBRX

Forte Biosciences (FBRX) Stock Price, News & Analysis

Forte Biosciences logo
$11.16 -0.10 (-0.89%)
Closing price 04:00 PM Eastern
Extended Trading
$10.98 -0.18 (-1.65%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Forte Biosciences Stock (NASDAQ:FBRX)

Key Stats

Today's Range
$10.73
$11.91
50-Day Range
$9.45
$14.66
52-Week Range
$4.11
$28.68
Volume
90,030 shs
Average Volume
62,972 shs
Market Capitalization
$138.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$68.00
Consensus Rating
Buy

Company Overview

Forte Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

FBRX MarketRank™: 

Forte Biosciences scored higher than 55% of companies evaluated by MarketBeat, and ranked 500th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Forte Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Forte Biosciences has only been the subject of 2 research reports in the past 90 days.

  • Read more about Forte Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Forte Biosciences are expected to grow in the coming year, from ($12.12) to ($3.68) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Forte Biosciences is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Forte Biosciences is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Forte Biosciences has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Forte Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    1.17% of the float of Forte Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Forte Biosciences has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Forte Biosciences has recently increased by 0.62%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Forte Biosciences does not currently pay a dividend.

  • Dividend Growth

    Forte Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.17% of the float of Forte Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Forte Biosciences has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Forte Biosciences has recently increased by 0.62%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Forte Biosciences has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Forte Biosciences this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for FBRX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Forte Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.90% of the stock of Forte Biosciences is held by insiders.

  • Percentage Held by Institutions

    77.63% of the stock of Forte Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Forte Biosciences' insider trading history.
Receive FBRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FBRX Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
Wall Street Zen Upgrades Forte Biosciences (NASDAQ:FBRX) to "Hold"
Forte Biosciences' (FBRX) Buy Rating Reaffirmed at Chardan Capital
See More Headlines

FBRX Stock Analysis - Frequently Asked Questions

Forte Biosciences' stock was trading at $22.71 at the start of the year. Since then, FBRX stock has decreased by 51.6% and is now trading at $10.9850.

Forte Biosciences, Inc. (NASDAQ:FBRX) released its quarterly earnings results on Thursday, August, 14th. The company reported ($0.96) earnings per share for the quarter, topping the consensus estimate of ($1.21) by $0.25.

Top institutional shareholders of Forte Biosciences include Orbimed Advisors LLC (18.19%), Federated Hermes Inc. (16.30%), Tybourne Capital Management HK Ltd. (11.95%) and BVF Inc. IL (8.94%). Insiders that own company stock include Paul A Wagner and Antony A Riley.
View institutional ownership trends
.

Shares of FBRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forte Biosciences investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), PayPal (PYPL), QUALCOMM (QCOM), Avino Silver & Gold Mines (ASM), Meta Platforms (META) and Zoom Communications (ZM).

Company Calendar

Last Earnings
8/14/2025
Today
8/27/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:FBRX
CIK
1419041
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

High Price Target
$75.00
Low Price Target
$61.00
Potential Upside/Downside
+503.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($16.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$35.48 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-85.38%
Return on Assets
-72.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.74
Quick Ratio
11.74

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.93 per share
Price / Book
1.42

Miscellaneous

Outstanding Shares
12,430,000
Free Float
11,699,000
Market Cap
$139.96 million
Optionable
Optionable
Beta
2.91

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:FBRX) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners